|
1
|
Hua W, Zhang LF, Wu YF, Liu XQ, Guo DS,
Zhou HL, Gou ZP, Zhao LC, Niu HX, Chen KP, et al: Incidence of
sudden cardiac death in China: Analysis of 4 regional populations.
J Am Coll Cardiol. 54:1110–1118. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Langhelle A, Tyvold SS, Lexow K, Hapnes
SA, Sunde K and Steen PA: In-hospital factors associated with
improved outcome after out-of-hospital cardiac arrest. A comparison
between four regions in Norway. Resuscitation. 56:247–263. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Granfeldt A: Organ dysfunction following
regional and global ischemia/reperfusion. Intervention with
postconditioning and adenocaine. Dan Med J. 59:B44962012.PubMed/NCBI
|
|
4
|
Adrie C, Adib-Conquy M, Laurent I, Monchi
M, Vinsonneau C, Fitting C, Fraisse F, Dinh-Xuan AT, Carli P,
Spaulding C, et al: Successful cardiopulmonary resuscitation after
cardiac arrest as a ‘sepsis-like’ syndrome. Circulation.
106:562–568. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Han F, Da T, Riobo NA and Becker LB: Early
mitochondrial dysfunction in electron transfer activity and
reactive oxygen species generation after cardiac arrest. Crit Care
Med 36 (11 Suppl). S447–S453. 2008. View Article : Google Scholar
|
|
6
|
Brookes P and Darley-Usmar VM: Hypothesis:
The mitochondrial NO (*) signaling pathway, and the transduction of
nitrosative to oxidative cell signals: An alternative function for
cytochrome C oxidase. Free Radic Biol Med. 32:370–374. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ischiropoulos H and Beckman JS: Oxidative
stress and nitration in neurodegeneration: Cause, effect, or
association? J Clin Invest. 111:163–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rossig L, Haendeler J, Hermann C, Malchow
P, Urbich C, Zeiher AM and Dimmeler S: Nitric oxide down-regulates
MKP-3 mRNA levels: Involvement in endothelial cell protection from
apoptosis. J Biol Chem. 275:25502–25507. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim YM, Bombeck CA and Billiar TR: Nitric
oxide as a bifunctional regulator of apoptosis. Circ Res.
84:253–256. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiao XY, Gao E, Yuan Y, Wang Y, Lau WB,
Koch W, Ma XL and Tao L: INO-4885 [5,10,15,20-tetra[N-(benzyl-4′-
carboxylate)- 2-pyridinium]-21H,23H-porphine iron(III) chloride], a
peroxynitrite decomposition catalyst, protects the heart against
reperfusion injury in mice. J Pharmacol Exp Ther. 328:777–784.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arstall MA, Sawyer DB, Fukazawa R and
Kelly RA: Cytokine-mediated apoptosis in cardiac myocytes: The role
of inducible nitric oxide synthase induction and peroxynitrite
generation. Circ Res. 85:829–840. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hung LM, Chen JK, Huang SS, Lee RS and Su
MJ: Cardioprotective effect of resveratrol, a natural antioxidant
derived from grapes. Cardiovasc Res. 47:549–555. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li D, Qu Y, Tao L, Liu H, Hu A, Gao F,
Sharifi-Azad S, Grunwald Z, Ma XL and Sun JZ: Inhibition of iNOS
protects the aging heart against beta-adrenergic receptor
stimulation-induced cardiac dysfunction and myocardial ischemic
injury. J Surg Res. 131:64–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mokni M, Limam F, Elkahoui S, Amri M and
Aouani E: Strong cardioprotective effect of resveratrol, a red wine
polyphenol, on isolated rat hearts after ischemia/reperfusion
injury. Arch Biochem Biophys. 457:1–6. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen M, Jia GL, Wang YM and Ma H:
Cardioprotective effect of resvaratrol pretreatment on myocardial
ischemia-reperfusion induced injury in rats. Vascul Pharmacol.
45:122–126. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goh SS, Woodman OL, Pepe S, Cao AH, Qin C
and Ritchie RH: The red wine antioxidant resveratrol prevents
cardiomyocyte injury following ischemia-reperfusion via multiple
sites and mechanisms. Antioxid Redox Signal. 9:101–113. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hassan-Khabbar S, Cottart CH, Wendum D,
Vibert F, Clot JP, Savouret JF, Conti M and Nivet-Antoine V:
Postischemic treatment by trans-resveratrol in rat liver
ischemia-reperfusion: A possible strategy in liver surgery. Liver
Transpl. 14:451–459. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gurusamy N, Lekli I, Mukherjee S, Ray D,
Ahsan MK, Gherghiceanu M, Popescu LM and Das DK: Cardioprotection
by resveratrol: A novel mechanism via autophagy involving the
mTORC2 pathway. Cardiovasc Res. 86:103–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen MH, Liu TW, Xie L, Song FQ, He T, Mo
SR and Zeng ZY: A simpler cardiac arrest model in the mouse.
Resuscitation. 75:372–379. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yin XL, Zhang W, Yang Y and Shen H:
Increasing expression of (CCAAT enhancer binding protein)
homologous protein induced by endoplasmic reticulum stress in
myocardium after cardiac arrest and resuscitation in rat.
Resuscitation. 83:378–385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Knapp J, Bergmann G, Bruckner T, Russ N,
Bottiger BW and Popp E: Pre- and postconditioning effect of
sevoflurane on myocardial dysfunction after cardiopulmonary
resuscitation in rats. Resuscitation. 84:1450–1455. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mukherjee S, Dudley JI and Das DK:
Dose-dependency of resveratrol in providing health benefits. Dose
Response. 8:478–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shen M, Wu RX, Zhao L, Li J, Guo HT, Fan
R, Cui Y, Wang YM, Yue SQ and Pei JM: Resveratrol attenuates
ischemia/reperfusion injury in neonatal cardiomyocytes and its
underlying mechanism. PLoS One. 7:e512232012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Boocock DJ, Faust GE, Patel KR, Schinas
AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher
AJ, et al: Phase I dose escalation pharmacokinetic study in healthy
volunteers of resveratrol, a potential cancer chemopreventive
agent. Cancer Epidemiol Biomarkers Prev. 16:1246–1252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Juan SH, Cheng TH, Lin HC, Chu YL and Lee
WS: Mechanism of concentration-dependent induction of heme
oxygenase-1 by resveratrol in human aortic smooth muscle cells.
Biochem Pharmacol. 69:41–48. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Safar P: Effects of the postresuscitation
syndrome on cerebral recovery from cardiac arrest. Crit Care Med.
13:932–935. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Senthil M, Brown M, Xu DZ, Lu Q, Feketeova
E and Deitch EA: Gut-lymph hypothesis of systemic inflammatory
response syndrome/multiple-organ dysfunction syndrome: Validating
studies in a porcine model. J Trauma. 60:958–967. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rubertsson S, Grenvik A and Wiklund L:
Blood flow and perfusion pressure during open-chest versus
closed-chest cardiopulmonary resuscitation in pigs. Crit Care Med.
23:715–725. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bradamante S, Barenghi L, Piccinini F,
Bertelli AA, De Jonge R, Beemster P and De Jong JW: Resveratrol
provides late-phase cardioprotection by means of a nitric oxide-
and adenosine- mediated mechanism. Eur J Pharmacol. 465:115–123.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu D, Bassuk J, Arias J, Kurlansky P,
Lozano H, Lamas G and Adams JA: Different roles of nitric oxide
synthase isoforms in cardiopulmonary resuscitation in pigs.
Resuscitation. 73:144–153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hung LM, Su MJ and Chen JK: Resveratrol
protects myocardial ischemia-reperfusion injury through both
NO-dependent and NO-independent mechanisms. Free Radic Biol Med.
36:774–781. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang HX, Duan GL, Wang CN, Zhang YQ, Zhu
XY and Liu YJ: Protective effect of resveratrol against
endotoxemia-induced lung injury involves the reduction of
oxidative/nitrative stress. Pulm Pharmacol Ther. 27:150–155. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsieh TC, Juan G, Darzynkiewicz Z and Wu
JM: Resveratrol increases nitric oxide synthase, induces
accumulation of p53 and p21 (WAF1/CIP1), and suppresses cultured
bovine pulmonary artery endothelial cell proliferation by
perturbing progression through S and G2. Cancer Res. 59:2596–2601.
1999.PubMed/NCBI
|
|
34
|
Wang A, Liu M, Liu X, Dong LQ, Glickman
RD, Slaga TJ, Zhou Z and Liu F: Up-regulation of adiponectin by
resveratrol: The essential roles of the Akt/FOXO1 and AMP-activated
protein kinase signaling pathways and DsbA-L. J Biol Chem.
286:60–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ji L, Fu F, Zhang L, Liu W, Cai X, Zhang
L, Zheng Q, Zhang H and Gao F: Insulin attenuates myocardial
ischemia/reperfusion injury via reducing oxidative/nitrative
stress. Am J Physiol Endocrinol Metab. 298:E871–E880. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang WQ, Zhang HF, Gao GX, Bai QX, Li R
and Wang XM: Adiponectin inhibits hyperlipidemia-induced platelet
aggregation via attenuating oxidative/nitrative stress. Physiol
Res. 60:347–354. 2011.PubMed/NCBI
|
|
37
|
Huang T, Gao D, Jiang X, Hu S, Zhang L and
Fei Z: Resveratrol inhibits oxygen-glucose deprivation-induced
MMP-3 expression and cell apoptosis in primary cortical cells via
the NF-kappaB pathway. Mol Med Rep. 10:1065–1071. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang H, Morgan B, Potter BJ, Ma L,
Dellsperger KC, Ungvari Z and Zhang C: Resveratrol improves left
ventricular diastolic relaxation in type 2 diabetes by inhibiting
oxidative/nitrative stress: In vivo demonstration with magnetic
resonance imaging. Am J Physiol Heart Circ Physiol. 299:H985–H994.
2010. View Article : Google Scholar : PubMed/NCBI
|
